Introduction
Normally, very small amounts of pleural fluid are present in the
pleural spaces, and fluid is not detectable by routine methods. When
certain disorders occur, excessive pleural fluid may accumulate and
cause pulmonary signs and symptoms. Simply put, pleural effusions
occur when the rate of fluid formation exceeds that of fluid
absorption. Once a symptomatic, unexplained pleural effusion occurs,
a diagnosis needs to be established.
Signs and Symptoms
Pleuritic chest pain, chest pressure, dyspnea, and cough are the
most common symptoms of pleural effusion. Pain may occur with little
fluid formation as the symptom is related to the intense
inflammation of the pleural surfaces. Chest pressure usually does
not occur until the effusion is in the moderate (500-1500 ml) to
large (>1500 ml) category. Dyspnea rarely occurs with small
effusions unless significant pleurisy is present and often the
patient will not complain of dyspnea until the effusion is massive
with contralateral mediastinal shift on the chest x-ray. Cough is
usually related to the associated atelectasis, which to some degree
accompanies all pleural effusions. Classic physical findings
associated with pleural effusions may occur when the volume begins
to exceed 500 ml and include diminished breath sounds, dullness to
percussion, reduced tactile and vocal fremitus, and occasionally a
pleural friction rub. In contrast to pneumonia and atelectasis,
crackles are not heard with an isolated pleural effusion.
Noninvasive Diagnostic Techniques
When the presence of a pleural effusion is suspected by physical
examination, confirmation with a chest x-ray is necessary. With some
pleural effusions, especially when subpulmonic in location (layering
below the lung but above the hemidiaphragm), a lateral decubitus
film usually confirms the presence of fluid. Pleural space
ultrasound is extremely helpful to locate small amounts or isolated
loculated pockets of fluid. Thoracentesis can be performed
simultaneously using ultrasound guidance. Chest CT is most helpful
to distinguish between parenchymal and pleural disease and may
demonstrate pleural thickening, pleural calcification, a pleural
based mass, or loculated collections of fluid.
Thoracentesis and Pleural Fluid Analysis
To establish the etiology, a thoracentesis usually needs to be
performed. Fifty to 100 ml of fluid are usually removed and sent for
analysis (See Table
14). Not every effusion needs to be tapped, but when the patient
has no obvious clinical cause for the effusion, is febrile, or has
pulmonary compromise, fluid should be removed. The first step is to
determine if the fluid is a transudate or an exudate. Transudative
effusions occur when systemic factors that influence the formation
and absorption of pleural fluid are altered (e.g., low serum
proteins and increased pulmonary venous pressure). Exudative
effusions occur when local factors that influence the formation and
absorption of fluid are altered (e.g., infection and malignancy).
The lactate dehydrogenase (LDH), protein levels or specific gravity
of the fluid can distinguish these two. Most agree that exudates
must meet one or more of the following criteria, whereas transudates
meet none:
- Pleural fluid/serum protein > 0.5 or absolute value > 3
g/dl.
- Pleural fluid/serum LDH > 0.6 or absolute value > 0.45
upper normal serum limit
- Pleural fluid specific gravity > 1.018
Once an effusion is categorized as transudative or exudative,
etiologic considerations narrow. Additional pleural fluid studies
that help to establish a diagnosis include glucose, amylase, white
blood cell counts with differential, and cytologic and microbiologic
examination.
Etiology of Pleural Effusions
Transudates: The causes of transudative pleural effusions are
listed in Table
15.
Congestive Heart Failure: This is the most common
cause of pleural effusion. Frequently the effusions are bilateral
(approximately 75% of the time) but may occur alone on either side
with the right side being more common. Fluid is usually straw
colored, with low white blood cell counts (<500 cells/mm3) and a
mononuclear cell predominance. With severe congestive heart failure,
fluid may persist in spite of vigorous diuresis.
Cirrhosis, Nephrotic Syndrome, and Hepatic
Hydrothorax: In disorders associated with low serum proteins
and ascites, bilateral effusions are common. Cell counts are low and
lymphocytes predominate. Glucose remains normal (>60 mg/dl).
Hepatic hydrothorax occurs in about 5% of patients with ascites and
cirrhosis. The effusion occurs (usually on the right side) because
of direct movement of peritoneal fluid through communications in the
hemidiaphragm.
Exudates: The causes of exudative pleural
effusions are listed in Table
16. The most common causes of exudative pleural effusions are
parapneumonic (associated with pneumonia), malignancy, pulmonary
embolism, trauma (including hemothorax and esophageal perforation),
collagen vascular disease (especially rheumatoid arthritis),
post-cardiac injury (including surgery), tuberculosis, trapped lung,
and atelectasis. The characteristics of pleural fluids are listed in
Table
17.
Parapneumonic Effusion: Bacterial pneumonias are
frequently associated with pleural effusions (as often as 50 % of
the time) and when they become complicated, require drainage.
Complicated parapneumonic effusions include empyema (the finding of
gross pus in the pleural space), those with positive pleural fluid
cultures or Gram stains, and those in which the microbiology is
negative but the patient continues to show signs of infection with
fever, severe pleuritic pain and leukocytosis. In this last category
the pleural fluid usually shows high white blood cell counts with
polymorphonuclear predominance, glucose <30 mg/dl, and high LDH
(>500 units/dl). Complicated parapneumonic effusions require
drainage by tube thoracoscopy. The patient who has pneumonia with a
small amount of pleural fluid present and is clinically responding
to antibiotic therapy (now afebrile, no pleuritic pain, normal white
blood cell count) does not require thoracentesis. By contrast, rapid
accumulation of pleural fluid in a patient with pneumonia is an
indication for immediate thoracentesis.
Malignant Effusions: Malignancy is the second most common cause
of exudative pleural effusions with lung (36%), breast (25%) and
lymphoma (10%) being the most frequent causes. Typical pleural fluid
characteristics include a mononuclear predominant exudate (average
2500 cells/mm3), with an average red blood cell count of 40,000
cells/mm3, normal glucose (>60mg/dl) and positive cytology. At
the time of diagnosis one-third of patients have a low pleural fluid
glucose (<60mg/dl), which is associated with more extensive
disease and a poorer prognosis.
Effusion Secondary to Pulmonary Embolism: These exudative
effusions are usually bloody, and associated with pleurisy and
dyspnea. The effusion may increase in size the first 24-48 hours
after initial anticoagulation. Unless there is significant pulmonary
compromise, or the effusion continues to increase, these effusions
can be observed. There are reports of transudative effusions
associated with pulmonary embolism, but atelectasis secondary to
splinting from pleurisy is a more likely cause.
Tuberculous Effusion: Typically, this predominantly lymphocytic
exudate is devoid of mesothelial cells and may occur without any
obvious parenchymal involvement. The glucose may be low (<60
mg/dl) and adenosine deaminase levels are usually elevated (>70
IU/l). Historically, in the non-immunocompromised host, pleural
fluid smears are rarely positive but pleural fluid cultures are
positive in 25%. In contrast, thoracoscopic pleural biopsy and
culture is positive more than 80% of the time. Initially the
tuberculin skin test (TST) may be negative but after a 6 to 8 week
observation time usually converts to positive. Although tuberculous
pleurisy that develops in the course of primary infection is a
self-limited disease that clears without treatment, in as many as
65% of these patients pulmonary tuberculosis or disease elsewhere
will develop within 5 years. If all tests, including the TST, are
negative but tuberculous pleurisy is suspected, a repeat TST should
be done and if positive the patient requires 6 months of multidrug
therapy.
Effusions Secondary to Collagen Vascular Disease: Effusions
secondary to rheumatoid arthritis are predominantly mononuclear cell
exudates, typically with very low glucose levels (<10mg/dl), high
titers of rheumatoid factor (>640) and a cloudy appearance
(pseudochylous or cholesterol effusions). They are usually moderate
in size and unilateral. In systemic lupus erythematosus effusions
are usually small, bilateral and are polymorphonuclear exudates. The
finding of an ANA titer that exceeds that of serum is diagnostic.
Severe pleurisy is frequent.
Miscellaneous: Atelectasis is a common cause of small to moderate
effusions. Frequently they are seen postoperatively or with
prolonged bed rest and inactivity. There are no unique diagnostic
features and these effusions usually fit exudative criteria, have
normal glucose levels, and WBC counts of 1000 to 2000 cells/mm3 with
mononuclear cell predominance. Transudates may occur with
atelectasis. Since this is a diagnosis of exclusion, other causes of
pleural effusions must be eliminated. Esophageal rupture and
pancreatitis produce polymorphonuclear-predominant exudative
effusions, with high amylase and normal or low glucose (< 30
mg/dl) values. Chylothorax occurs when the thoracic duct is
disrupted and is characterized by the presence of chylomicrons and
triglyceride values of >110 mg/dl in the pleural fluid. Lymphoma,
trauma, and thoracic surgery are the most common causes of
chylothorax. Dressler’s syndrome may occur as a complication of
myocardial infarction or open-heart surgery; the resulting pleural
fluid demonstrates a polymorphonuclear-predominant exudate without
specific findings. With a trapped lung (one that cannot fully expand
secondary to a visceral pleural peel), exudative pleural fluid fills
the pleural space and the characteristics of the fluid depend on the
etiology (e.g., malignancy, post-parapneumonic, trauma).
Diagnostic Thoracoscopy and Pleural Biopsy
Thoracoscopy is an excellent technique to determine the etiology
of an undiagnosed exudative pleural effusion. The procedure is
superior to the old closed pleural biopsy techniques because of its
higher diagnostic yield. A rigid thoracoscope with a cold light
source is used and second point of entry is necessary to provide
biopsy forceps access to the pleural space. This technique continues
to be most helpful in diagnosing malignant effusions (including
mesothelioma), tuberculosis, and trapped lung.
When to Refer
Depending on local medical practice, referral to determine if
thoracentesis is necessary and to perform the thoracentesis may be
most appropriate. Because some imaging techniques including
ultrasound and chest CT may be necessary to coordinate thoracentesis
and chest tube placement, referral to combine these efforts is
indicated. In patients with persistent and undiagnosed pleural
effusions, or effusions in severely ill patients with pneumonia,
referral to facilitate prompt diagnostic and therapeutic measures is
recommended. This includes evaluation for thoracoscopy, chest tube
placement and pleurodesis.
Medicolegal Concerns
Most medicolegal issues involving pleural disease are usually
related to complications that occur in the following situations: 1)
lack of appropriate follow-up (e.g., complicated parapneumonic
effusion resulting in fibrothorax), 2) system failure where
physicians do not receive critical data (e.g., a positive TB culture
at 8 weeks), and 3) missed diagnosis of a potentially life
threatening event such as a pulmonary embolism. ALWAYS, always
follow up on pleural fluid cultures and cytologies.
Summary
Pleural effusions are associated with many systemic disorders.
Thoracentesis to determine if the pleural fluid is a transudate or
an exudate coupled with other appropriate diagnostic studies
provides a diagnosis most of the time. Because pleural fluid
findings are often nonspecific (except for positive cytology and
bacteriology), clinical correlation and response to therapy are
critical. Not every pleural fluid study needs to be ordered on every
pleural effusion. Clinical judgement remains the key.
References
Heffner JE. Evaluating diagnostic tests in the pleural space.
Clin Chest Med 1998;19.2:277-293. Excellent somewhat sophisticated
article which looks at the most commonly used pleural fluid studies
to determine between transudates and exudates.
Light RL. Disorders of the Pleura. Harrison’s Principles of
Internal Medicine 1998; chapter 262, 13472-1475. A classic review of
etiology and features of pleural effusions, which is well
summarized.
Sahn SA. Malignancy metastatic to the pleura. Clin Chest Med
1998;19.2:351-361. Well organized and well written article that
covers pathogenesis, clinical presentation, pleural fluid
characteristics, diagnosis, prognosis and treatment of malignant
effusions. An excellent reference list is provided.
Roper WH. Primary serofibrinous pleural effusion in military
personnel. Am Rev Tuberc 1955;71:616-634. A classic article hat
drives home the point that an untreated tuberculous effusion will
usually spontaneously resolve; however, there is up to a 65% chance
of the patient developing active pulmonary or extrapulmonary
tuberculosis within five years.
Kinasewitz GT. Pleuritis and Pleural Effusion. Pulmonary and
Critical Care Medicine on CD-ROM 1997; Chapter One. The absolute
best detailed current review covering all aspects of pleural
disease. Excellent tables, well referenced. |